Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report

Detalles Bibliográficos
Autor principal: Yamamoto, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Editorial Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292127/
https://www.ncbi.nlm.nih.gov/pubmed/32743406
http://dx.doi.org/10.1002/iju5.12080
_version_ 1783546043829321728
author Yamamoto, Yoshiyuki
author_facet Yamamoto, Yoshiyuki
author_sort Yamamoto, Yoshiyuki
collection PubMed
description
format Online
Article
Text
id pubmed-7292127
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72921272020-07-30 Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report Yamamoto, Yoshiyuki IJU Case Rep Editorial Comment John Wiley and Sons Inc. 2019-05-09 /pmc/articles/PMC7292127/ /pubmed/32743406 http://dx.doi.org/10.1002/iju5.12080 Text en © 2019 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Editorial Comment
Yamamoto, Yoshiyuki
Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
title Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
title_full Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
title_fullStr Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
title_full_unstemmed Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
title_short Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
title_sort editorial comment to tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: a case report
topic Editorial Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292127/
https://www.ncbi.nlm.nih.gov/pubmed/32743406
http://dx.doi.org/10.1002/iju5.12080
work_keys_str_mv AT yamamotoyoshiyuki editorialcommenttotumorlysissyndromefollowingcabazitaxeladministrationformetastaticcastrationresistantprostatecanceracasereport

Ejemplares similares